Map3K7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Map3K7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Mitogen-Activated Protein Kinase Kinase Kinase 7 | |
|---|---|
| Gene Symbol | MAP3K7 |
| Full Name | Mitogen-Activated Protein Kinase Kinase Kinase 7 (TAK1) |
| Chromosome | 6q15 |
| NCBI Gene ID | 6885 |
| OMIM | 602614 |
| Ensembl ID | ENSG00000171081 |
| UniProt ID | O43318 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Cardiofaciocutaneous Syndrome |
MAP3K7 encodes TAK1 (Transforming Growth Factor Beta-Activated Kinase 1), a serine/threonine kinase that serves as a central mediator of inflammatory, stress-activated, and developmental signaling pathways. TAK1 is activated by cytokines (IL-1, TNF-α, TGF-β), TLRs, and physical stress. Once activated, TAK1 phosphorylates IKKβ and MKK4/7, leading to activation of NF-κB and JNK/AP-1 pathways respectively. TAK1 is essential for embryonic development, cell survival, proliferation, and differentiation. In the brain, TAK1 regulates neuroinflammation, synaptic plasticity, and neuronal viability.
Wide expression in immune cells and neural tissue. Expressed in microglia, astrocytes, and neurons. Constitutively expressed at moderate levels, rapidly activated by stimuli.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | P106L | Risk factor | Enhanced neuroinflammation |
| Parkinson's Disease | Splice variants | Risk factor | Altered stress response |
| ALS | R80H | Risk factor | Dysregulated inflammation |
| Cardiofaciocutaneous | Various | Autosomal dominant | Developmental defects |
Map3K7 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Map3K7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.